Fauna Bio hunts for novel obesity drugs in $494m Lilly partnership
Longevity Technology - 21-Dec-2023Fauna's AI platform explores animal data to unlock breakthroughs in weight management
Join the club for FREE to access the whole archive and other member benefits.
Co-founder and CEO at Fauna Bio
Veterinarian-scientist, Co-founder and CEO at Fauna Bio.
Ashley’s research focused on translational science and veterinary informatics at Stanford, earning a PhD in Cancer Biology and her work spans >20 peer-reviewed publications, including Cell, Nature and Nature Medicine and several book chapters. She is a boarded avian veterinarian with specialty training in exotic/non-traditional species. She is a co-founder of the Exotic Species Cancer Research Alliance and incoming president of the Association of Avian Veterinarians.
Visit website: https://www.faunabio.com/blog/founder-story-ashley-zehnder
See also: Fauna Bio - Developing human therapeutics from animal genomics
Details last updated 06-Sep-2021
Fauna's AI platform explores animal data to unlock breakthroughs in weight management
Another reminder of the amount of research, with multiple approaches, about to go into clinical trials
By investigating self-healing mechanisms in animals, Fauna bio aims to cure human diseases.